Use access key #2 to skip to page content.
$9.12 0.12 (1.33%)
10/7/2008 11:21 AM

Mylan Laboratories, Inc. (MYL)

CAPS Rating:
****

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

View All Commentary (MYL)

Recs

0

Avatar stockmarkid (60.64) Submitted: 7/17/08 5:34 PM : Outperform Start Price: $13.04 MYL Score: -13.77

Mylan produces quality, reliable generic pharmaceutical products that I believe their product portfolio will continue to grow. I believe Mylan is a long term hold as I expect the generic drug industry to grow strong in the future.

Report this Post Replies: 0 | Reply

Featured Broker Partners